Multimodal biomedical AI
The increasing availability of biomedical data from large biobanks, electronic health records,
medical imaging, wearable and ambient biosensors, and the lower cost of genome and …
medical imaging, wearable and ambient biosensors, and the lower cost of genome and …
Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic sco** review
Digital health technology (DHT) has the potential to revolutionize healthcare delivery but its
uptake has been low in clinical and research settings. The factors that contribute to the …
uptake has been low in clinical and research settings. The factors that contribute to the …
Digital approaches to enhancing community engagement in clinical trials
Digital approaches are increasingly common in clinical trial recruitment, retention, analysis,
and dissemination. Community engagement processes have contributed to the successful …
and dissemination. Community engagement processes have contributed to the successful …
Artificial intelligence and machine learning for clinical pharmacology
DK Ryan, RH Maclean, A Balston… - British Journal of …, 2024 - Wiley Online Library
Artificial intelligence (AI) will impact many aspects of clinical pharmacology, including drug
discovery and development, clinical trials, personalized medicine, pharmacogenomics …
discovery and development, clinical trials, personalized medicine, pharmacogenomics …
Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension-2021 NHLBI workshop report
Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood
pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of …
pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of …
The need for increased pragmatism in cardiovascular clinical trials
The majority of cardiovascular randomized controlled trials (RCTs) test interventions in
selected patient populations under explicitly protocol-defined settings. Although these …
selected patient populations under explicitly protocol-defined settings. Although these …
[HTML][HTML] Decentralised clinical trials: ethical opportunities and challenges
Fuelled by adaptations to clinical trial implementation during the COVID-19 pandemic,
decentralised clinical trials are burgeoning. Decentralised clinical trials involve many digital …
decentralised clinical trials are burgeoning. Decentralised clinical trials involve many digital …
Implementation of digital health technology in clinical trials: the 6R framework
Implementation of digital health technology in clinical trials: the 6R framework | Nature Medicine
Skip to main content Thank you for visiting nature.com. You are using a browser version with …
Skip to main content Thank you for visiting nature.com. You are using a browser version with …
Participation of Black Americans in cancer clinical trials: current challenges and proposed solutions
Low participation of Black Americans in cancer clinical trials is a well-established
predicament. Many factors resulted in this current dilemma with racism being the …
predicament. Many factors resulted in this current dilemma with racism being the …
Clinical trials of immunotherapy in triple-negative breast cancer
Purpose Immunotherapy has started to transform the treatment of triple-negative breast
cancer (TNBC), in part due to the unique immunogenicity of this breast cancer subtype. This …
cancer (TNBC), in part due to the unique immunogenicity of this breast cancer subtype. This …